KR20030025606A - Method of refining and microcapsuling tea extract - Google Patents
Method of refining and microcapsuling tea extract Download PDFInfo
- Publication number
- KR20030025606A KR20030025606A KR1020010058736A KR20010058736A KR20030025606A KR 20030025606 A KR20030025606 A KR 20030025606A KR 1020010058736 A KR1020010058736 A KR 1020010058736A KR 20010058736 A KR20010058736 A KR 20010058736A KR 20030025606 A KR20030025606 A KR 20030025606A
- Authority
- KR
- South Korea
- Prior art keywords
- filtrate
- tea extract
- extraction
- ethyl acetate
- layer
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 20
- 241001122767 Theaceae Species 0.000 title claims abstract 7
- 238000007670 refining Methods 0.000 title description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000000706 filtrate Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 8
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 4
- 239000011780 sodium chloride Substances 0.000 claims abstract description 4
- 238000000605 extraction Methods 0.000 claims description 15
- 239000010410 layer Substances 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 12
- 238000001694 spray drying Methods 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 9
- 239000002904 solvent Substances 0.000 claims description 8
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 229920001661 Chitosan Polymers 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 229920000159 gelatin Polymers 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 4
- 235000019322 gelatine Nutrition 0.000 claims description 4
- 235000011852 gelatine desserts Nutrition 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000003094 microcapsule Substances 0.000 claims description 3
- 239000012044 organic layer Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 21
- 235000013824 polyphenols Nutrition 0.000 abstract description 21
- 239000000047 product Substances 0.000 abstract description 13
- 239000002778 food additive Substances 0.000 abstract description 7
- 235000013373 food additive Nutrition 0.000 abstract description 7
- 230000036541 health Effects 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 abstract 2
- 229910052593 corundum Inorganic materials 0.000 abstract 2
- 229910001845 yogo sapphire Inorganic materials 0.000 abstract 2
- 229910004878 Na2S2O4 Inorganic materials 0.000 abstract 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract 1
- 235000019341 magnesium sulphate Nutrition 0.000 abstract 1
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 abstract 1
- 244000269722 Thea sinensis Species 0.000 description 32
- 235000013616 tea Nutrition 0.000 description 30
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 5
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 4
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 235000015872 dietary supplement Nutrition 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- -1 lipid peroxide Chemical class 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940030275 epigallocatechin gallate Drugs 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- HTRXGEPDTFSKLI-UHFFFAOYSA-N butanoic acid;ethyl acetate Chemical compound CCCC(O)=O.CCOC(C)=O HTRXGEPDTFSKLI-UHFFFAOYSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/18—Extraction of water soluble tea constituents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/20—Removing unwanted substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/22—Drying or concentrating tea extract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
- A23F3/32—Agglomerating, flaking or tabletting or granulating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 조차(粗茶)추출물로부터 얻어진 고순도의 티 폴리페놀이 포함된 차추출물에 관한 것으로, 보다 상세하게는 티 폴리페놀을 추출, 분리 및 정제하여 이를 마이크로캡슐화 하는 방법에 관한 것이다.The present invention relates to a tea extract containing high-purity tee polyphenols obtained from even extracts, and more particularly, to a method of extracting, separating and purifying tee polyphenols and microencapsulating them.
차는 약 4000년 전부터 사람이 섭취하여 왔으며 현재 전세계적으로 물 다음으로 많이 사용되는 음료수이다. 차의 종류를 대별하면 녹차, 우롱차 혹은 홍차 등으로 나눌 수 있다. 녹차의 생산량은 연간 250만톤에 이르며 차가 세계적인 음료수로 사용되는 이유는 차속에 항산화제 성분이 포함되어 노화방지 및 기타 효과가 탁월하기 때문이며, 그 주성분은 폴리페놀(polyphenol; catechin 혹은 tannine)인 것으로 알려져 왔다.Tea has been ingested by humans for about 4000 years ago and is now the second most used beverage in the world after water. The types of tea can be divided into green tea, oolong tea or black tea. The production of green tea reaches 2.5 million tons per year, and the reason why tea is used as a worldwide drink is because it contains antioxidants in the tea, which is excellent for anti-aging and other effects. The main ingredient is known as polyphenol (polyphenol; catechin or tannine). come.
이러한 티 폴리페놀(tea polyphenol)의 분리정제 및 생리활성에 관한 연구는약 20년 전부터 매우 활발하게 이루어지고 있으며 외국에서는 약 2 ~ 3년 전부터 이 제품을 이용한 건강보조식품, 식품첨가물과 기능성 화장품 등에 사용되고 있으며 매년 사용되는 양이 증대되고 있는 실정이다. 이러한 이유는 티 폴리페놀이 가지고 있는 생리활성이 매우 광범위하게 적용된다는 사실이 알려졌기 때문이다.The research on the separation and physiological activity of the tea polyphenol has been conducted very actively for about 20 years. In foreign countries, it has been used for about 2 ~ 3 years for health supplements, food additives and functional cosmetics. It is being used and the amount used is increasing every year. This is due to the fact that the physiological activity of tea polyphenols is widely applied.
즉, 혈청 콜레스테롤 함량을 크게 감소시켜 고혈압과 동맥경화 예방 및 구취제거 등의 구강건강작용, 지방작용을 촉진시켜 과산화지질로 변화되는 것을 방지하기 위한 노화방지 작용과 자외선에 의해 프리라디칼(free radical)이 생산됨으로써 피부의 중요한 요소인 콜라겐과 엘라스틴을 파괴하는 것을 방지하는 피부 노화방지 효과, 간장보호 및 신장기능 향상효과, 혈소판 응집방지 및 혈압강화 작용, 면역력 증가 및 지속효과, 항돌연변이 효과와 비만방지, 소화기능 향상, 구강위생과 구강건강 및 구취제거 효과 등에 대한 많은 생리활성 연구가 이미 보고되고 있다.In other words, it significantly reduces serum cholesterol and prevents hypertension and arteriosclerosis, promotes oral health such as removing bad breath, and promotes fat, thereby preventing aging and preventing free radicals from being changed into lipid peroxide. This production prevents the destruction of collagen and elastin, which are important elements of the skin, prevents skin aging, hepatic protection and renal function, platelet aggregation and blood pressure strengthening, immunity increase and persistence, antimutagenic and obesity prevention. Many studies on bioactivity have been reported for improvement of digestive function, oral hygiene and oral health and bad breath removal effect.
특히, 약 2년 전부터 녹차에서 티 폴리페놀을 분리하는 기술이 개발되었고, 국내에서도 국산화가 성공을 거두었다. 그러나, 종래의 분리 정제방법에 의하면 티 폴리페놀의 함량이 매우 낮은 편이며, 제품의 색깔이 진한 갈색으로 건강보조식품, 식품첨가물 또는 화장품으로 사용하는데 어려운 점이 있다.In particular, a technology for separating tea polyphenols from green tea has been developed about two years ago, and localization has been successful in Korea. However, according to the conventional separation and purification method, the content of thiopolyphenol is very low, and the color of the product is dark brown, which makes it difficult to use as a health supplement, food additive or cosmetic.
본 발명은 상기와 같은 문제점을 해결하기 위하여 창작된 것으로서, 본 발명의 목적은 조녹차 추출물로부터 순도가 높은 티 폴리페놀이 함유된 차추출물을 정제하는 방법을 제공하고 이를 마이크로 캡슐화 함으로써 식품첨가물이나 건강보조식품으로 사용할 수 있도록 하는 것이다.The present invention has been made to solve the above problems, an object of the present invention is to provide a method for purifying tea extracts containing high-purity tea polyphenols from crude green tea extract and microencapsulates the food additives or health It can be used as a supplement.
상기와 같은 본 발명의 목적은, 천연 조차추출물 100g에 정제수를 750㎖의 비율로 용해하여 용액을 만드는 단계(1); 상기 용액에 Na2S2O4를15g, EDTA-2Na를 5g, 활성탄소를 20g 및 Al2O3를 16.7g의 비율로 첨가하여 교반 후 여과하는 단계(2); 여과 후 남은 여액에 대하여 정제수를 100㎖의 비율로 첨가하여 세척하고 상기 여액에 NaCl을 2g의 비율로 첨가하여 용해하는 단계(3);An object of the present invention as described above, step (1) to make a solution by dissolving purified water in a ratio of 750 ml in 100 g of natural edodes extract; 15 g of Na 2 S 2 O 4 , 5 g of EDTA-2Na, 20 g of activated carbon, and 16.7 g of Al 2 O 3 were added to the solution, followed by filtering after stirring; Adding (3) to the remaining filtrate after filtration, adding purified water at a rate of 100 ml, and adding and dissolving NaCl at a rate of 2 g to the filtrate (3);
상기 용액에 초산에틸(ethyl acetate)을 500㎖의 비율로 첨가하여 1차 추출하는 단계(4); 수층에 초산에틸을 500㎖의 비율로 첨가하여 2차 추출하는 단계(5); 추출한 유기층에 Al2O3를 16.7g및 MgSO4를 60g의 비율로 첨가하여 교반 후 여과하는 단계(6);Ethyl acetate (ethyl acetate) is added to the solution at a rate of 500 ml for primary extraction (4); Adding (5) ethyl acetate to the aqueous layer at a rate of 500 ml for secondary extraction; Adding 66.7 g of Al 2 O 3 and 60 g of MgSO 4 to the extracted organic layer, followed by stirring and filtering (6);
염화메틸렌(methylene chloride)이 2ℓ의 비율로 채워진 타 용기에 상기 여과액을 적가하는 단계(7); 0 ~ 5℃에서 1시간 동안 교반 후 여과하는 단계(8); 상기 여과물에 대하여 염화메틸렌을 200㎖의 비율로 첨가하여 세척하는 단계(9); 및 상기 여과물을 건조하여 차추출물을 수득하는 단계(10);로 이루어지는 것을 특징으로 하는 차추출물을 정제하는 방법에 의하여 달성된다.Adding (7) the filtrate to another vessel filled with methylene chloride at a rate of 2 liters; Filtering after stirring at 0-5 ° C. for 1 hour (8); Washing (9) adding methylene chloride to the filtrate at a rate of 200 ml; And drying the filtrate to obtain a tea extract (10). A method of purifying tea extract, characterized in that consisting of.
본 발명에서는 순도가 낮은 차추출물로부터 고순도의 티 폴리페놀이 포함된 차추출물에 대한 추출, 분리와 정제, 마이크로 캡슐화 등을 통하여 종래의 제품보다 순도가 높으며 미백색으로 개선된 제품을 대량생산하는 기술을 적용하였다.The present invention provides a technique for mass-producing a product having a higher purity and whitening than a conventional product by extracting, separating, purifying and microencapsulating a tea extract containing high purity tea polyphenol from a low purity tea extract. Applied.
또한, 본 발명에서는 정제 과정의 중간 단계에서 추출용매층인 초산에틸층을 분무건조법을 이용하여 미황색의 고순도의 티 폴리페놀이 포함된 차추출물을 얻을수 있다.In addition, in the present invention, the tea extract containing the light yellow high purity thi polyphenol may be obtained by spray drying the ethyl acetate layer, which is an extraction solvent layer, in the middle of the purification process.
또한, 본 발명에서는 상기와 같은 차추출물을 에탄올 혹은 물에 용해하여 분무건조법으로 건조하여 결정화 하는 것을 특징으로 한다.In addition, the present invention is characterized in that the above-mentioned tea extract is dissolved in ethanol or water and dried by spray drying to crystallize.
그리고, 본 발명에서는 고순도의 티 폴리페놀이 포함된 차추출물의 마이크로 캡슐화된 제품을 얻기 위하여 정제 중간에 추출된 초산에틸층을 정제수로 재추출하여 탄수화물, 유당, 젤라틴, 덱스틴, 아미노산 또는 키토산 등으로 캡슐화 하여 분무건조법으로 결정화시켜 다양한 형태의 마이크로 캡슐화된 고순도의 녹차추출물을 얻을 수 있다.In the present invention, in order to obtain a micro-encapsulated product of tea extract containing high-purity tee polyphenol, the ethyl acetate layer extracted in the middle of refining is re-extracted with purified water to give carbohydrate, lactose, gelatin, dextine, amino acid or chitosan. It is encapsulated by crystallization by spray drying to obtain a variety of microcapsules of high purity green tea extract.
본 발명에서는 화학정 정제방법을 이용하여 티 폴리페놀의 함량을 98% 이상으로 향상시키는 반면 제품의 색깔 역시 진갈색의 조추출물을 세계적으로 가장 좋은 색깔인 미백색으로 개선하였다.In the present invention, while improving the content of thiopolyphenol to 98% or more by using a chemical tablet purification method, the color of the product also improved the dark brown crude extract to the white color, the best color in the world.
본 발명에서 사용한 추출용매로는 초산에틸, 부탄올, 펜탄올 등을 사용하며, 결정용매로는 염화메틸렌, 클로로포름, n-헥산 등을 사용하며, 탈색제로는 활성탄, Na2S2O4, Na2S2O5, Na2SO3, EDTA, Al2O3등을 사용하는 것을 특징으로 한다. 또한, 여러 식품첨가물에 다양하게 사용하기 위하여 여려 종류의 아미노산, 탄수화물, 젤라틴, 유당, 덱스틴 또는 키토산 등을 사용하여 마이크로 캡슐화 함으로써 다양한 제품을 제조할 수 있다.Ethyl acetate, butanol, pentanol, etc. are used as the extraction solvent used in the present invention, methylene chloride, chloroform, n-hexane, etc. are used as the crystalline solvent, and activated carbon, Na 2 S 2 O 4 , Na It is characterized by using 2 S 2 O 5 , Na 2 SO 3 , EDTA, Al 2 O 3 and the like. In addition, a variety of products can be prepared by microencapsulating various types of amino acids, carbohydrates, gelatin, lactose, dextine or chitosan for use in various food additives.
본 발명의 그 밖의 목적, 특정한 장점 및 신규한 특징들은 첨부된 도면들과 연관되어지는 이하의 발명의 상세한 설명과 바람직한 실시예로부터 더욱 분명해질것이다.Other objects, specific advantages, and novel features of the present invention will become more apparent from the following detailed description of the invention and the preferred embodiments in connection with the accompanying drawings.
도 1은 본 발명의 일 실시예에 따른 차추출물을 정제하는 방법에 관한 순서도이다.1 is a flowchart illustrating a method for purifying tea extract according to an embodiment of the present invention.
이하 본 발명에 따른 차추출물을 정제하고 마이크로캡슐화 하는 방법에 대하여 실시예를 들어 구체적으로 설명하기로 한다.Hereinafter, a method for purifying and microencapsulating tea extract according to the present invention will be described in detail with reference to Examples.
<실시예 1><Example 1>
도 1은 본 발명의 일 실시예에 따른 차추출물을 정제하는 방법에 관한 순서도이다. 도 1에 도시된 바와 같이, 1단계는 천연 조차추출물(티 폴리페놀 순도 : 95.0%, 진한 갈색) 100g을 정제수 750 ㎖로 용해하여 용액을 만드는 단계이다. 2단계는 상기 용액에 Na2S2O415g, EDTA-2Na 5g, 활성탄소 20g 및 Al2O316.7g을 첨가하여 1시간 동안 교반 후 여과하는 단계이다.1 is a flowchart illustrating a method for purifying tea extract according to an embodiment of the present invention. As shown in FIG. 1, the first step is to prepare a solution by dissolving 100 g of natural even ethanol extract (tea polyphenol purity: 95.0%, dark brown) in 750 ml of purified water. In step 2 , 15 g of Na 2 S 2 O 4 , 5 g of EDTA-2Na, 20 g of activated carbon, and 16.7 g of Al 2 O 3 were added to the solution, followed by stirring for 1 hour, followed by filtration.
그 다음으로 3단계는 여과 후 남은 여액을 정제수 100㎖로 세척하고 상기 여액에 NaCl 20g을 첨가하여 용해하는 단계이다. 4단계는 상기 용액에 초산에틸(ethyl acetate) 500㎖로 1차 추출하는 단계이다. 5단계는 수층에 초산에틸 500㎖를 넣고 2차 추출하는 단계이다. 6단계는 추출한 유기층에 Al2O316.7g및 MgSO460g을 첨가하여 30분동안 교반 후 여과하는 단계이다.The third step is to wash the remaining filtrate after filtration with 100 ml of purified water and dissolve by adding 20 g of NaCl to the filtrate. Step 4 is a step of first extraction with 500 mL of ethyl acetate in the solution. In the fifth step, 500 ml of ethyl acetate is added to the aqueous layer and the second extraction is performed. Step 6 is adding 16.7 g of Al 2 O 3 and 60 g of MgSO 4 to the extracted organic layer, followed by stirring for 30 minutes and then filtering.
그 다음으로 7단계는 염화메틸렌(methylene chloride) 2ℓ가 채워진 타 용기에 상기 여과액을 1시간동안 적가하는 단계이다. 8단계는 0 ~ 5℃에서 1시간 동안 교반 후 여과하는 단계이다. 9단계는 상기 여과물을 염화메틸렌 200㎖로 세척하는 단계이다. 10단계는 상기 여과물을 건조하여 차추출물을 수득하는 단계이다.Subsequently, step 7 is a step of dropwise adding the filtrate to another container filled with 2 liters of methylene chloride for 1 hour. Step 8 is a step of filtering after stirring for 1 hour at 0 ~ 5 ℃. Step 9 is washing the filtrate with 200 ml of methylene chloride. Step 10 is to dry the filtrate to obtain a tea extract.
본 실시예에서는 미백색의 목적물을 92.0g 얻었다. 목적물을 분석한 결과 카페인(caffein)이 1.0% 이하, 에피갈로카테킨 갈레이트(epigallocatechin gallate)가 50% 이상, 갈로카테킨 갈레이트(gallocatechin gallate)가 16% 이상, 에피카테킨 갈레이트(epicatechin gallate)가 22% 이상이었다.In this example, 92.0 g of an off-white target product was obtained. Caffeine (1.0% or less), epigallocatechin gallate (50% or more), gallocatechin gallate (16% or more), epicatechin gallate (epicatechin gallate) More than 22%.
<실시예 2><Example 2>
조차추출물(티 폴리페놀 순도 90.0%, 진한 갈색) 100g을 사용하여 실시예 1과 같이 정제하여 목적물 80.3g을 얻었으며 순도 및 색깔은 실시예 1과 비슷하였다.Even 100 g of extract (tea polyphenol 90.0%, dark brown) was purified as in Example 1 to obtain 80.3 g of the target and the purity and color were similar to Example 1.
<실시예 3><Example 3>
조차추출물(티 폴리페놀 순도 80.0%, 진한 갈색) 100g을 사용하여 실시예 1과 같이 정제하여 목적물 71.2g을 얻었으며 순도 및 색깔은 실시예 1과 비슷하였다.Even 100 g extract (tea polyphenol purity 80.0%, dark brown) was purified as in Example 1 to obtain the target product 71.2g and the purity and color was similar to Example 1.
<실시예 4><Example 4>
조차추출물(티 폴리페놀 순도 70.0%, 진한 갈색) 100g을 사용하여 실시예 1과 같이 정제하여 목적물 62.8g을 얻었으며 순도 및 색깔은 실시예 1과 비슷하였다.Even 100 g of extract (tea polyphenol purity 70.0%, dark brown) was purified as in Example 1 to obtain 62.8 g of the target and the purity and color were similar to Example 1.
<실시예 5>Example 5
실시예 1 ~ 4에서와 같은 방법으로 정제하는 과정 중, 도 1에 도시된 바와 같이 4단계 이후의 30 단계는 추출용매층인 초산에틸층을 분무건조법에 의하여 결정화하 하는 단계이다. 본 실시예 5에서의 목적물의 수득율과 분석결과는 실시예 1~ 4의 각 결과와 비슷하였다.As shown in FIG. 1, step 30 after step 4 is to crystallize the ethyl acetate layer, which is an extraction solvent layer, by spray drying. The yield and analysis results of the target product in Example 5 were similar to the results of Examples 1 to 4.
<실시예 6><Example 6>
실시예 1 ~ 4에서와 같은 방법으로 정제하는 과정 중, 도 1에 도시된 바와 같이 10 단계 이후의 40 단계는 상기 차추출물을 에탄올 혹은 물에 용해하는 단계이다. 41 단계는 이를 분무건조법으로 건조하여 결정화 하는 단계이다. 본 실시예 6에서의 목적물의 수득율과 분석결과는 실시예 1 ~ 4의 각 결과와 비슷하였다.In the process of purifying in the same manner as in Examples 1 to 4, as shown in FIG. 1, step 40 after step 10 is a step of dissolving the tea extract in ethanol or water. Step 41 is a step of drying and crystallizing it by spray drying. Yield and analysis of the target product in Example 6 were similar to the results of Examples 1 to 4.
<실시예 7><Example 7>
실시예 1 ~ 4에서와 같은 방법으로 정제하는 과정 중, 도 1에 도시된 바와 같이 5단계 이후의 20 단계는 초산에틸층에 물을 700㎖의 비율로 첨가하여 1차 추출하는 단계이다. 21 단계는 상기 초산에틸층에 물을 300㎖의 비율로 첨가하여 2차 추출하는 단계이다. 22단계는 상기와 같이 추출된 용액을 약 1/2 정도로 농축하는 단계이다. 23 단계는 상기 농축물에 대하여 탄수화물, 향료, 젤라틴, 유당, 덱스틴, 아미노산 혹은 키토산을 사용하여 분무건조법으로 마이크로캡슐화 하는 단계이다.In the process of purifying in the same manner as in Examples 1 to 4, as shown in FIG. 1, step 20 after step 5 is a step of primary extraction by adding water to the ethyl acetate layer at a rate of 700 ml. In step 21, water is added to the ethyl acetate layer at a rate of 300 ml to perform second extraction. Step 22 is to concentrate the extracted solution to about 1/2. Step 23 is a step of microencapsulating the concentrate by spray drying using carbohydrate, flavor, gelatin, lactose, dexine, amino acid or chitosan.
여기서 분무건조법이라 함은 코아물질(core material)에 부형제, 유화제, 안정제 등을 첨가하여 이를 용매에 용해 또는 현탁시켜 노즐 또는 디스크로 분무하고, 동시에 열풍의 유입으로 순간적으로 건조시키는 방법이다. 열풍은 일반적으로 150 ~ 200℃로 고온이나, 기계장치에 의하여 순간적으로 증발잠열을 없애주므로 비교적 열에 불안정한 것도 캡슐화 시킬 수 있다. 급속히 용매를 증발시키므로 피막은 상당히 견고해진다.Here, the spray drying method is a method of adding excipients, emulsifiers, stabilizers, etc. to a core material, dissolving or suspending it in a solvent and spraying it with a nozzle or a disk, and at the same time instantaneously drying by inflow of hot air. Hot air is generally 150 ~ 200 ℃ high temperature, but because of the instantaneous removal of latent heat by the mechanical device can be encapsulated even relatively unstable heat. As the solvent evaporates rapidly, the coating becomes quite firm.
이하의 표 1에서는 실시예 1 ~ 4에서의 결과를 종합적으로 나타내었다.Table 1 below shows the results in Examples 1 to 4 comprehensively.
실시예 1 ~ 7에서 얻은 목적물의 순도는 모두 티 폴리페놀의 순도가 98% 이상, 카테친이 80% 이상, 카페인(caffein)이 1.0% 이하, 에피갈로카테친 갈레이트(epigallocatechin gallate)가 50% 이상, 갈로카테친 갈레이트(gallocatechin gallate)가 16% 이상, 에피카테친 갈레이트(epicatechin gallate)가 22% 이상이었다. 뿐만 아니라 순도 70%이하의 천연 티 폴리페놀에 있어서도 같은 방법으로 정제하여 상기 실시예 1 ~ 4에서와 같이 미백색의 순도가 높은 수득물을 얻었다.Purity of the targets obtained in Examples 1 to 7 were all 98% or more purity of polypolyphenol, 80% or more of catechin, 1.0% or less of caffein, 50% of epigallocatechin gallate. In the above, gallocatechin gallate (gallocatechin gallate) was more than 16%, epicatechin gallate (epicatechin gallate) was more than 22%. In addition, the purification was performed in the same manner for the natural tee polyphenol having a purity of 70% or less to obtain a white-white high purity product as in Examples 1 to 4 above.
본 발명에 따른 티 폴리페놀의 주요 생리활성 기능으로는 체내에 유해물질인 활성산소나 프리-라디칼(free radical)에 대한 강력한 항산화 효과가 있으며 암세포를 성장시키는 유로키나제(urokinase)의 활동을 차단시킴으로써 항암효과를 나타내며, 티 폴리페놀은 앞에서 언급한 것 이외에 대표적 병원성 균들인 이질균, 장티프스균, 포도상구균 및 비브리오균의 세균성장을 억제함으로써 감염증 예방 및 항균능력을 증가시켜 준다.The main physiological activity of the thiopolyphenol according to the present invention is a powerful antioxidant effect on free radicals or free radicals, which are harmful substances in the body, and anticancer by blocking the activity of urokinase that grows cancer cells. In addition to the foregoing, thi polyphenols increase the prevention of infectious diseases and increase the antibacterial ability by inhibiting the bacterial growth of the representative pathogenic bacteria, dysentery, typhoid, staphylococci and vibrio.
상기 언급한 바와 같이 본 발명에 따른 차추출물을 정제하는 방법에 의하면, 티 폴리페놀이 98% 이상으로 매우 순도가 높은 제품을 생산할 수 있으며, 또한 진갈색의 조추출물을 미백색으로 정제할 수 있으며, 이를 건강보조식품, 식품첨가물 혹은 화장품의 재료로 용이하게 사용할 수 있다.As mentioned above, according to the method for purifying the tea extract according to the present invention, it is possible to produce a product having a very high purity of polypolyphenol of 98% or more, and also to extract the dark brown crude extract to a white color. It can be easily used as a supplement for health supplements, food additives or cosmetics.
또한, 상기 티 폴리페놀을 마이크로 캡슐화 함으로써 쓰고 떫은 맛을 제거하여 여러 분야의 건강보조식품 혹은 식품첨가물로 폭넓게 이용될 수 있는 특징이 있다.In addition, by using the micro-encapsulation of the tea polyphenol has a feature that can be widely used as a health supplement food or food additives of various fields by removing the bitter taste.
비록 본 발명이 상기 언급된 바람직한 실시예와 관련하여 설명되어졌지만, 발명의 요지와 범위로부터 벗어남이 없이 다양한 수정이나 변형을 하는 것이 가능하다. 따라서 첨부된 특허청구범위는 본 발명의 요지에 속하는 이러한 수정이나 변형을 포함한다.Although the present invention has been described in connection with the above-mentioned preferred embodiments, it is possible to make various modifications or variations without departing from the spirit and scope of the invention. Accordingly, the appended claims include such modifications and variations as fall within the spirit of the invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0058736A KR100423241B1 (en) | 2001-09-21 | 2001-09-21 | Method of refining and microcapsuling tea extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2001-0058736A KR100423241B1 (en) | 2001-09-21 | 2001-09-21 | Method of refining and microcapsuling tea extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030025606A true KR20030025606A (en) | 2003-03-29 |
KR100423241B1 KR100423241B1 (en) | 2004-03-18 |
Family
ID=27725095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0058736A KR100423241B1 (en) | 2001-09-21 | 2001-09-21 | Method of refining and microcapsuling tea extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100423241B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020131866A1 (en) * | 2018-12-18 | 2020-06-25 | International Flavors & Fragrances Inc. | Microcapsule compositions prepared from polysaccharides |
WO2020131890A1 (en) * | 2018-12-18 | 2020-06-25 | International Flavors & Fragrances Inc. | Microcapsule compositions |
CN115669761A (en) * | 2022-10-10 | 2023-02-03 | 广州合诚三先生物科技有限公司 | Microcapsule powder containing tea extract and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0420589A (en) * | 1990-05-16 | 1992-01-24 | Mitsui Norin Kk | Manufacture of green tea polyphenol |
JPH04182480A (en) * | 1990-11-19 | 1992-06-30 | Shokuhin Sangyo High Separeeshiyon Syst Gijutsu Kenkyu Kumiai | Purification of tea catechins |
US5593617A (en) * | 1994-09-12 | 1997-01-14 | Hoffmann-Laroche Inc. | Photochemically polymerizable liquid crystals |
JPH09322710A (en) * | 1996-06-03 | 1997-12-16 | Minato Seiyaku Kk | Production of tea extract containing catechins |
-
2001
- 2001-09-21 KR KR10-2001-0058736A patent/KR100423241B1/en active IP Right Grant
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020131866A1 (en) * | 2018-12-18 | 2020-06-25 | International Flavors & Fragrances Inc. | Microcapsule compositions prepared from polysaccharides |
WO2020131890A1 (en) * | 2018-12-18 | 2020-06-25 | International Flavors & Fragrances Inc. | Microcapsule compositions |
CN115669761A (en) * | 2022-10-10 | 2023-02-03 | 广州合诚三先生物科技有限公司 | Microcapsule powder containing tea extract and preparation method and application thereof |
CN115669761B (en) * | 2022-10-10 | 2024-02-02 | 广州合诚三先生物科技有限公司 | Microcapsule powder containing tea extract and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR100423241B1 (en) | 2004-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007001893A (en) | Catechin composition and method for production of the same | |
JP2007282568A (en) | Method for producing refined green tea extract | |
JP2013535500A (en) | Urushi extract with increased content of active flavonoid compound and method for producing the same | |
US8993749B2 (en) | Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the eriocitrin-containing material | |
WO2004080995A1 (en) | Process for producing proanthocyanin-rich material | |
JP2003146898A (en) | Hyperlipemia-improving agent | |
TWI610680B (en) | Olive extract containing Des Rhamnosyl Acteoside | |
KR20190060023A (en) | Process for producing beverages containing active ingredients of Omija and Aronia extract and beverages produced therefrom | |
JP2010246530A (en) | Polyphenol composition | |
KR100423241B1 (en) | Method of refining and microcapsuling tea extract | |
US20070154580A1 (en) | Antiviral Morinda Citrifolia L. Based Formulations and Methods of Administration | |
JP2003334022A (en) | Endurance-improving food composition | |
WO2005099486A1 (en) | Process for preparing lagerstroemia speciosa l. extract | |
US20060251744A1 (en) | Method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons | |
JP2003146899A (en) | Skin-improving agent | |
KR102604237B1 (en) | Composition for enhancing the bioavailability of fat-soluble vitamins | |
JP2003095965A (en) | Hypertension-preventing and treating medicine | |
JPH04300836A (en) | Hepatic dysfunction preventive agent and functional food having preventive action on hepatic dysfunction | |
JP7350304B2 (en) | Allergic rhinitis symptom suppressant | |
JP3819413B1 (en) | Food containing food ingredients with bitter or astringent taste | |
JP6807064B2 (en) | Powdered or granular beverages and their manufacturing methods | |
JP2005082546A (en) | alpha-GLUCOSIDASE INHIBITOR | |
KR20110019789A (en) | Composition for coated rice composed of catechin compounds and beta-glucan | |
EP2586451B1 (en) | Composition for preventing and/or alleviating hangover comprising extracts of Sophora flavescens | |
KR101752476B1 (en) | A process for purifying procyanidins from extract of Lindera obtusiloba Blume |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130130 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140115 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150303 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20170302 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20180305 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20190304 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20200304 Year of fee payment: 17 |